Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.41 USD | -0.96% | -6.69% | +17.94% |
Apr. 30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.94% | 3.8B | |
+18.42% | 47.02B | |
+48.77% | 41.86B | |
+0.67% | 41.76B | |
-4.27% | 28.8B | |
+11.70% | 26.05B | |
-21.82% | 19.15B | |
+3.54% | 12.55B | |
+28.22% | 12.34B | |
-4.55% | 11.82B |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Transcript : Alvotech, 2023 Earnings Call, Mar 21, 2024